In the latest edition of its digest, DealMarket looks at, among other things: the preference for alternatives and private equity as expressed by pension funds and endowments; Tower Watson's top five predictions for global M&A in 2013; and the potential for India's biotech sector to reach USD 100m in the next 12 years.